Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2025-12-25 @ 3:09 AM
NCT ID: NCT05338905
Eligibility Criteria: Inclusion Criteria: * PATIENTS: Age \>= 18 years of age * PATIENTS: Diagnosed with biopsy-proven, non-metastatic squamous cell carcinoma of head and neck * PATIENTS: Scheduled to start curative-intent radiation therapy within 4 weeks * PATIENTS: Able to provide informed consent in English * PATIENTS: Able to read and write in English * PATIENTS: Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related assessment * PATIENTS' INFORMED CAREGIVER (e.g. family members, friends): They are verbally identified by eligible patients as a caregiver * PATIENTS' INFORMED CAREGIVER (e.g. family members, friends): They are not receiving any payment to provide care for patients * PATIENTS' INFORMED CAREGIVER (e.g. family members, friends): Able to provide informed consent in English * PATIENTS' INFORMED CAREGIVER (e.g. family members, friends): Able to read and write in English Exclusion Criteria: * PATIENTS: Diagnosed with metastatic head and neck cancer * PATIENTS: Eligible for palliative-intent radiation therapy only * PATIENTS: Pregnant female participants * PATIENTS: Unwilling or unable to follow protocol requirements * PATIENTS: Any condition which in the Investigator's opinion deems the participant an unsuitable candidate
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT05338905
Study Brief:
Protocol Section: NCT05338905